Sanofi Pasteur withdraws application for pandemic vaccine

Sanofi Pasteur is withdrawing its marketing authorisation application for Emerflu, a vaccine intended for prophylaxis of influenza in the event of a pandemic involving the influenza A virus subtype, H5N1, the European Medicines Agency said.